Quad-C Management has completed the sale of Boulder Scientific Company, a Colorado maker of specialty chemicals, to Iron Path Capital, the private equity firm said on 11 November 2026. Terms were not disclosed.
Why Iron Path Capital is buying Boulder Scientific Company
Quad-C said Boulder Scientific has differentiated technical capabilities in organometallic and complex synthetic chemistry.
Deal terms and financing
Financial terms were not disclosed. Piper Sandler was exclusive financial adviser and White & Case legal counsel to Boulder Scientific.
Market context
Quad-C, based in Charlottesville, Virginia, invested in Boulder Scientific in 2019 in a recapitalisation of the owner-operated business. Iron Path Capital, founded in 2021, invests in healthcare and specialty industrial companies and previously backed PureTech Scientific's US$137m purchase of Chemours' glycolic acid business.
